Recent studies suggest GLP-1s, the weight loss and diabetes drugs, may both prevent cancer and slow its progression. While weight loss is known to curb cancer risks, GLP-1s may act on other brain and metabolic pathways to prevent cancer.
There is mounting evidence to suggest GLP-1 obesity treatments also help reduce cancer risk, according to several recent studies. The studies are correlative, but appear to show the drugs not only reverse the carcinogenic risks that come with obesity... [3763 chars]